BDBM703893 7-(2-fluorobenzyl)-4-methyl-1,5-naphthyridin-2- amine. LCMS [M + 1]: 268.2. 1H NMR (400 MHz, CD3OD) $#948; = 8.47 (d, J = 2.0 Hz, 1H), 7.64 (d, J = 1.2 Hz, 1H), 7.36 (dt, J = 1.7, 7.6 Hz, 1H), 7.33- 7.27 (m, 1H), 7.19-7.15 (m, 1H), 7.15-7.09 (m, 1H), 6.88 (d, J = 1.0 Hz, 1H), 4.19 (s, 2H), 2.62 (d, J = 1.0 Hz, 3H).::US20240368153, Example 2-2
SMILES Cc1cc(N)nc2cc(Cc3ccccc3F)cnc12
InChI Key InChIKey=VVTAPBHDFPYXBZ-UHFFFAOYSA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 3 hits for monomerid = 703893
TargetProtein arginine N-methyltransferase 5 (PRMT5) and Methylosome protein WDR77 (MEP-50)(Human)
Mirati Therapeutics
US Patent
Mirati Therapeutics
US Patent
Affinity DataIC50: 354nMAssay Description:Table A1: A recombinant human dual expressed Avi PRMT5/His-MEP50) protein (corresponding to amino acids for PRMT5 2-637, and 2-342 for MEP50 expresse...More data for this Ligand-Target Pair
TargetProtein arginine N-methyltransferase 5 (PRMT5) and Methylosome protein WDR77 (MEP-50)(Human)
Mirati Therapeutics
US Patent
Mirati Therapeutics
US Patent
Affinity DataKd: 5.29E+3nMAssay Description:Table A2: In vivo biotinylated PRMT5-MEP50 was diluted to 4.5 μM in 25 mM Bicine pH 7.6, 100 mM NaCl, 1 mM TCEP, and 0.05% Tween-20 and injected at 5...More data for this Ligand-Target Pair
TargetProtein arginine N-methyltransferase 5 (PRMT5) and Methylosome protein WDR77 (MEP-50)(Human)
Mirati Therapeutics
US Patent
Mirati Therapeutics
US Patent
Affinity DataKd: 3.91E+4nMAssay Description:Table A2: In vivo biotinylated PRMT5-MEP50 was diluted to 4.5 μM in 25 mM Bicine pH 7.6, 100 mM NaCl, 1 mM TCEP, and 0.05% Tween-20 and injected at 5...More data for this Ligand-Target Pair
